Feature | EP Lab | August 09, 2021

Heart Rhythm Society 2021 Late-Breaking Clinical Trials in Electrophysiology

The latest science in EP to treat cardiac arrhythmias

Heart Rhythm Society, HRS, 2021 Late-Breaking Clinical Trials in Electrophysiology. #HRS #HRS2021 #HRS21 #Heartrhythm21

July 28, 2021 — Here is the complete list of late-breaking clinical trials (LBCT) and links to articles on all of them from the Heart Rhythm Society (HRS) 2021 meeting. For more information on the meeting, visit https://heartrhythm.com.

Late Breaking Clinical Trials and Registry
Thursday, July 29, 8:15 AM - 9:15 AM CDT

   • STROKE VT Trial: Safety And Efficacy Of Periprocedural Direct Oral Anticoagulant Versus Aspirin Use For Reduction Of The Risk Of Cerebrovascular Events In Patients Undergoing Ventricular Tachycardia Radiofrequency Catheter Ablation. Presented by Dhanunjaya R. Lakkireddy.

   • A Randomized Pilot Study Of Perioperative Spinal Cord Stimulation To Prevent Post-CABG Atrial Fibrillation: 30-day Safety And Efficacy Outcomes. Presented by Alexander B. Romanov.

   • Clinical Outcomes Of Left Bundle Branch Area Pacing Compared To Right Ventricular Pacing: Results From The Geisinger-Rush Conduction System Pacing. Presented by Parikshit S. Sharma.

   • A Randomized Trial Of Early First-Line Catheter Ablation For Ventricular Tachycardia: Results From The Pan-Asia United States Prevention Of Sudden Cardiac Death Trial (PAUSE-SCD). Presented by Roderick Tung.

Late Breaking Clinical Innovations
Thursday, July 29, 12:45 PM - 1:45 PM CDT

   • Continuous ECG Monitoring Versus Mobile Telemetry: A Comparison Of Arrhythmia Diagnostics Between Human And Algorithm Dependent Systems. Presented by Mark Willcox, M.D.

   • Leadless LV Stimulation With Wise-CRT System - Initial Experience In New U.S. Centers: Results From Phase I Of Solve-CRT Study (non-randomized, Roll-in Phase).Presented by Jagmeet P Singh.

   • Ultralow Temperature Cryoablation For Atrial Fibrillation, Primary Outcome Results On Efficacy And Safety. The Cryocure-2 Study. Presented by Tom De Potter.

   • Analysis Of Behavior Of Af Sources With Electrographic Flow Mapping. Presented by David E. Haines.

Late Breaking Clinical Trials Updates
Friday, July 30, 9:30 AM - 10:30 AM CDT

   • Oral Contraceptive Use And The Risk Of Cardiac Events In Women With Congenital Long QT Syndrome. Presented by Ilan Goldenberg.

   • Early Rhythm Control Therapy In Patients With Atrial Fibrillation And Heart Failure (EAST – AFNET 4). Presented by Andreas Rillig.

   • Economic Outcomes Of Ablation Versus Drug Therapy In CABANA. Presented by Derek Chew.

   • Safety And Effectiveness Of Multi-site Pacing In Initial Non-responders To Conventional Cardiac Resynchronization Therapy. Presented by Samir F. Saba.


Late Breaking Science
Friday, July 30, 12:45 PM - 1:45 PM CDT

   • Sinus Node Sparing Hybrid Thoracoscopic Ablation Outcomes In Patients With Inappropriate Sinus Tachycardia (Susruta-IST Registry). Presented by Dhanunjaya R. Lakkireddy.

   • Left Bundle Branch Optimized Cardiac Resynchronization Therapy (LOT-CRT): Results From International LBBAP Collaborative Study Group. Presented by Marek Jastrzebski.

   • Ganglionated Plexus Ablation To Prevent Atrial Fibrillation (GANGLIA-AF Trial). Presented by Min-young Kim.

   • First-in-human Clinical Experience With A Novel 4-D ICE Catheter During Catheter Ablation And LAA Closure Procedures. Presented by Vivek Y. Reddy.


Related HRS Conference Coverage:

VIDEO: Multi-Site Pacing Effective in Initial Nonresponders to Conventional Cardiac Resynchronization Therapy — Interview with Samir Saba, M.D.

Northwestern Medicine First in U.S. to Use Live 3D Intracardiac Echo for EP Procedure

Tyrx Absorbable Antibacterial Envelope Effectively Reduces Infections in Cardiac Device Patients with Hematomas

AliveCor and Acutus Partner to Evaluate Arrhythmia Management and Treatment

Bardy Carnation Ambulatory Monitor Patch Decreases Diagnosis Time and Readmissions


VIDEO: EP Trends and New Technology From Biosense Webster at HRS 2021

Significant and Sustained Reduction in Blood Pressure in MODERATO II Trial Using BackBeat Cardiac Neuromodulation Therapy

Biosense Webster Showcases New Data and Latest Innovations at Heart Rhythm 2021

New Study Aims to Show Effectiveness of CRT-D for Heart Failure Patients With Atrial Fibrillation

Biotronik Implantable Cardiac Monitor Receives Prestigious Industry Award



Related Content

Feature | HRS | By Lars Thording, PhD

Innovation in medical technology exists to improve patient outcomes, increase surgical efficiency and enhance patient ...

Home June 11, 2024
News | HRS

May 19, 2024 — A physician-initiated prospective, randomized clinical trial sponsored by the National Heart, Lung, and ...

Home May 18, 2024
News | HRS

May 18, 2024 — The Heart Rhythm Society (HRS) has announced the findings of three new studies demonstrating the safety ...

Home May 18, 2024
News | HRS

September 21, 2023 — Vektor Medical, developers of the only FDA-cleared technology to accurately map arrhythmias using ...

Home September 21, 2023
Feature | HRS | By Melinda Taschetta-Millane

The Heart Rhythm Society (HRS) announced the full lineup of speakers and sessions, including late-breaking clinical ...

Home May 17, 2023
News | HRS

May 2, 2023 — The Heart Rhythm Society (HRS) is making final preparations for its Annual Heart Rhythm Meeting, HRS2023 ...

Home May 02, 2023
Feature | HRS | By Lars Thording, PhD

Hospitals in the U.S. are suffering under a debilitating post-pandemic financial and operational trauma. Ascension ...

Home August 23, 2022
News | HRS

August 4, 2022 — The Heart Rhythm Society (HRS) is a professional society representing a diverse population of ...

Home August 04, 2022
News | HRS

May 17, 2022 — Heart Rhythm 2022 has come to a close, and the Heart Rhythm Society has released some stats regarding ...

Home May 17, 2022
Videos | HRS

Interview with Andrew D. Krahn, M.D., FHRS, head of the division of cardiology at St. Paul’s Hospital, and professor of ...

Home May 22, 2020
Subscribe Now